These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease. Gendron LM; Nyberg A; Saey D; Maltais F; Lacasse Y Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012290. PubMed ID: 30306545 [TBL] [Abstract][Full Text] [Related]
45. Antibiotic prophylaxis for leptospirosis. Win TZ; Perinpanathan T; Mukadi P; Smith C; Edwards T; Han SM; Maung HT; Brett-Major DM; Lee N Cochrane Database Syst Rev; 2024 Mar; 3(3):CD014959. PubMed ID: 38483067 [TBL] [Abstract][Full Text] [Related]
46. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Poole P; Sathananthan K; Fortescue R Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966 [TBL] [Abstract][Full Text] [Related]
47. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease. Fukuda N; Horita N; Kaneko A; Goto A; Kaneko T; Ota E; Kew KM Cochrane Database Syst Rev; 2023 Jun; 6(6):CD012066. PubMed ID: 37276335 [TBL] [Abstract][Full Text] [Related]
49. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Kew KM; Seniukovich A Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010115. PubMed ID: 24615270 [TBL] [Abstract][Full Text] [Related]
50. Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease. Lenferink A; Brusse-Keizer M; van der Valk PD; Frith PA; Zwerink M; Monninkhof EM; van der Palen J; Effing TW Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011682. PubMed ID: 28777450 [TBL] [Abstract][Full Text] [Related]
51. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis. Smith S; Rowbotham NJ Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968 [TBL] [Abstract][Full Text] [Related]
52. Interventions for the prevention of recurrent erysipelas and cellulitis. Dalal A; Eskin-Schwartz M; Mimouni D; Ray S; Days W; Hodak E; Leibovici L; Paul M Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009758. PubMed ID: 28631307 [TBL] [Abstract][Full Text] [Related]
53. Self-management for bronchiectasis. Kelly C; Grundy S; Lynes D; Evans DJ; Gudur S; Milan SJ; Spencer S Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012528. PubMed ID: 29411860 [TBL] [Abstract][Full Text] [Related]
54. Different classes of antibiotics given to women routinely for preventing infection at caesarean section. Williams MJ; Carvalho Ribeiro do Valle C; Gyte GM Cochrane Database Syst Rev; 2021 Mar; 3(3):CD008726. PubMed ID: 33661539 [TBL] [Abstract][Full Text] [Related]
60. Interventions to reduce Staphylococcus aureus in the management of eczema. George SM; Karanovic S; Harrison DA; Rani A; Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]